MATHEMATICAL MODELING OF IN-VIVO TUMOR-IMMUNE INTERACTIONS FOR THE CANCER IMMUNOTHERAPY USING MATURED DENDRITIC CELLS
From MaRDI portal
Publication:4628893
DOI10.1142/S0218339018500080zbMath1409.92112OpenAlexW2789835686WikidataQ113777146 ScholiaQ113777146MaRDI QIDQ4628893
Jamshid Hajati, Abazar Arabameri, Davud Asemani
Publication date: 25 March 2019
Published in: Journal of Biological Systems (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1142/s0218339018500080
Related Items (6)
Parameter estimation and sensitivity analysis for a model of tumor-immune interaction in the presence of immunotherapy and chemotherapy ⋮ Dynamic aspects of tumour–immune system interaction under a periodic immunotherapy ⋮ Mathematical modelling for the role of CD\(4^+\)T cells in tumor-immune interactions ⋮ Tumor Control, Elimination, and Escape through a Compartmental Model of Dendritic Cell Therapy for Melanoma ⋮ Treatment of melanoma with dendritic cell vaccines and immune checkpoint inhibitors: a mathematical modeling study ⋮ Bacillus Calmette Guerin (BCG) immunotherapy for bladder cancer: a control and mathematical analysis
Cites Work
- A cancer treatment based on synergy between anti-angiogenic and immune cell therapies
- Mathematical model creation for cancer chemo-immunotherapy
- A model for effects of adaptive immunity on tumor response to chemotherapy and chemoimmunotherapy
- Modeling immunotherapy of the tumor -- immune interaction
- Nonlinear dynamics of immunogenic tumors: Parameter estimation and global bifurcation analysis
- A mathematical model of tumor-immune evasion and siRNA treatment
- A mathematical model of tumor-immune interactions
- Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretations
- Interactions between the immune system and cancer: A brief review of non-spatial mathematical models
- A MATHEMATICAL MODEL OF PANCREATIC CANCER WITH TWO KINDS OF TREATMENTS
This page was built for publication: MATHEMATICAL MODELING OF IN-VIVO TUMOR-IMMUNE INTERACTIONS FOR THE CANCER IMMUNOTHERAPY USING MATURED DENDRITIC CELLS
